Newsfeeds - Spark Newswire

2 minute read

News

ObsEva Shares Rise 25% Premarket After Company Announced a Corporate Update, Including Increase in Share Capital on Monday

Today, 9:58 AM

ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing andcommercializing novel therapies for women's health, announced today that its board of directors approved on January 28, 2022 an increase ofits share capital from 85,220,471 to 108,620,471 shares through the issuance of 23,400,000 newly registered shares at an issue price of 1/13of a Swiss Franc each.

OBSV

1 minute read

18 Stocks Moving in Monday’s Pre-Market Session

By Lisa Levin

Today, 9:58 AM

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

ARDS

32 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 9:58 AM

On Thursday, 615 stocks hit new 52-week lows.

AAOI

2 minute read

28 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 9:58 AM

Gainers Genfit SA (NASDAQ: GNFT) shares jumped 33.6% to $4.41 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor.

ABEO

4 minute read

The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx

By Shanthi Rexaline

Today, 9:58 AM

Here's a roundup of top developments in the biotech space over the last 24 hours.

ALVR

3 minute read

20 Stocks Moving in Friday’s Pre-Market Session

By Lisa Levin

Today, 9:58 AM

Gainers Genfit SA (NASDAQ: GNFT) rose 47.5% to $4.90 in pre-market trading. Ipsen and GENFIT reported an exclusive licensing agreement for Elafibranor.

ABEO

4 minute read

The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares

By Shanthi Rexaline

Today, 9:58 AM

Here's a roundup of top developments in the biotech space over the last 24 hours.

ABBV

1 minute read

10 Biggest Price Target Changes For Monday

By Lisa Levin

Today, 9:58 AM

Citigroup cut Merck & Co., Inc. (NYSE: MRK) price target from $105 to $85. Merck shares fell 2% to $77.55 in pre-market trading.

ABEO

1 minute read

HC Wainwright & Co. Maintains Buy on ObsEva, Lowers Price Target to $15

By Benzinga Newsdesk

Today, 9:58 AM

HC Wainwright & Co. analyst Raghuram Selvaraju maintains ObsEva (NASDAQ:OBSV) with a Buy and lowers the price target from $17 to $15.

OBSV

2 minute read

20 Stocks Moving in Monday’s Pre-Market Session

By Lisa Levin

Today, 9:58 AM

Gainers Astra Space, Inc. (NASDAQ: ASTR) rose 39.6% to $13.30 in pre-market trading after declining around 3% on Friday. Astra Space recently reported a Q3 loss of $0.06 per share.

AGC